Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Under-The-Radar Systems In Biotechnology That Could Create Upside
Seeking Alpha
Sunday, October 7, 2012 - 11:48am
tags:
OncoSec Medical, Celsion, AngioDynamics, Accuray
Weekend Recap: Biotech Madness
Seeking Alpha
Sunday, October 7, 2012 - 11:47am
tags:
Sarepta Therapeutics, Synta Pharmaceuticals, Arena Pharmaceuticals, Arqule, Amarin, Acadia, Aeterna Zentaris
Did This High Dividend Stock Just Lower the Bar?
Motley Fool
Sunday, October 7, 2012 - 11:44am
tags:
PDL Biopharma
Why Does Billionaire Thomas Steyer’s Farallon Love This Pharmaceutical Company?
Motley Fool
Sunday, October 7, 2012 - 11:43am
tags:
Horizon Pharma
3 Biotech Stocks That Will Be Making Big Moves
Motley Fool
Sunday, October 7, 2012 - 11:42am
tags:
MannKind, Dendreon, Spectrum Pharmaceuticals
Vivus Announces Suit Dismissal and 4 Healthcare Stocks in Demand
Wall Street Cheat Street
Sunday, October 7, 2012 - 11:41am
tags:
Vivus, Arena Pharmaceuticals, Dendreon, Pfizer, Insmed
Healthcare Business Review: Watson Gets EU Approval, Stryker’s Bad News
Wall Street Cheat Street
Saturday, October 6, 2012 - 12:11pm
tags:
Watson, Actavis, M&A, Questcor, Acthar
Fosun set to tap HK stock market for US$600m
South China Morning Post
Saturday, October 6, 2012 - 12:09pm
tags:
Fosun Pharmaceutical
Pfizer to challenge Indian ruling overturning cancer drug patent
Economic Times, India
Saturday, October 6, 2012 - 12:06pm
tags:
Pfizer, Sutent
New Diabetes Drug Can Bolster J&J’s $74 Value
Trefis
Saturday, October 6, 2012 - 12:05pm
tags:
JNJ, diabetes, canagliflozin, type 2 diabetes
Anacor Pharmaceuticals Announces That GSK Has Discontinued Clinical Development Of GSK2251052
Bioresearch Online
Saturday, October 6, 2012 - 12:04pm
tags:
GSK2251052, Anacor, GSK, UTI
Pharma’s Diabetes War Escalates
Motley Fool
Saturday, October 6, 2012 - 11:54am
tags:
diabetes, Merck, Amalin
Alnylam-ISIS Venture Prices IPO
Yahoo/Zacks
Saturday, October 6, 2012 - 11:50am
tags:
Alnylam, Isis Pharmaceuticals
Extending the Diabetes Dominance
Motley Fool
Saturday, October 6, 2012 - 11:49am
tags:
Merck, MK-3102, Januvia, diabetes, type 2 diabetes
Step Back From That Overnight Triple, Sir
Motley Fool
Saturday, October 6, 2012 - 11:47am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, muscular dystrophy
Vorapaxar For Patients With Previous MI And Merck's Bottom Line
Seeking Alpha
Saturday, October 6, 2012 - 11:46am
tags:
Vorapaxar, Merck, myocardial infarction
Is Zalicus Really A Bad Investment?
Seeking Alpha
Saturday, October 6, 2012 - 11:45am
tags:
Zalicus
Investors, Take A Look At This Global Pharmaceutical Company
Motley Fool
Saturday, October 6, 2012 - 11:44am
tags:
Eli Lilly
Pfizer’s U.S. Losses Questioned as Overseas Profit Soars
Bloomberg
Saturday, October 6, 2012 - 11:43am
tags:
Pfizer
This Big Pharma Pair Parts Ways
Motley Fool
Saturday, October 6, 2012 - 11:42am
tags:
Bristol-Myers Squibb, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.